Pre-market
Loading markets…

Advertisement

Stocks

Why Bausch Health Companies Inc stock is sliding today

By Wealth Awesome -

This move is archived. Current quotes and coverage live on the stock page.

Stocks & ETFs:BHC.TO

Follow BHC

Photos provided by Pexels

Bausch Health Companies Inc is experiencing a notable decline in its stock price, raising concerns among investors.

Bausch Health Companies Inc (BHC.TO) is having a tough trading day, with its stock dropping by 4.32% to close at CA$8.42. This decline follows a brief surge after positive earnings reports, leaving investors questioning whether these recent gains can last.

Advertisement

Bausch Health Companies Inc

BHC.TO

Full stock page →

BHC.TO

Bausch Health Companies Inc

Source:WealthAwesomeWealthAwesome
↑ $0.81 (10.34%)
120 day period
$6.25$7.95$9.65Apr 21Jul 16Oct 9

Market cap

$3.23B

52W high

$11.08

52W low

$6.10

1W change

+5.78%

Beta

0.37

Analyst Price Targets

Based on analyst covering BHC · as of Sep 17, 2026

📉

Wall Street analysts forecast BHC stock price to fall 18.5% over the next 12 months.

Consensus

Bearish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$7.01

-18.5% Upside

Current Price

C$8.60

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on BHC's historical volatility

HistoricalForecast68%95%
C$6.06C$8.11C$10.16C$12.21C$14.27C$16.32TodayJun 3Aug 7Oct 9Nov 21Jan 4Feb 16

30-Day Vol

35.8%

Annualized

90-Day Vol

65.9%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$10.33

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$9.17C$8.11 – C$10.37
60 trading daysC$9.73C$8.17 – C$11.59
90 trading daysC$10.33C$8.34 – C$12.79

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: Despite recent earnings growth, Bausch Health's stock is under pressure, highlighting the volatility and uncertainty surrounding its recovery strategy.

Bausch Health's stock down 4.32% today

The company has lost 32.7% year-to-date, significantly underperforming compared to its industry.

Bull case

Bausch Health recently reported a strong second quarter, with revenues up 12.7% and a turnaround in net income. This could signal potential for future growth if the company manages its resources effectively.

Bear case

Investor caution is clear as institutional participation has decreased, indicating a lack of confidence in Bausch Health's ability to maintain its recovery trajectory.

Recent Performance Overview

Advertisement

Bausch Health's stock has faced significant volatility, losing 32.7% year-to-date. The recent 4.32% drop follows a strong earnings report that initially boosted investor sentiment. However, this decline suggests that market confidence may be wavering as institutional investors reduce their holdings.

Earnings Report Highlights

In its latest earnings report, Bausch Health announced a net income of $260 million, a significant increase from the previous year. Revenue growth of 12.7% was driven by strong performance in its Salix and Solta Medical segments. Despite these positive figures, the stock's recent decline indicates that investors are cautious about the company's long-term profitability and growth strategy.

Institutional Investor Sentiment

Data shows a notable drop in institutional participation, with hedge fund holdings decreasing by 24.4%. This trend signals a lack of confidence among larger investors regarding Bausch Health's ability to sustain its recovery. As the company navigates its turnaround strategy, continued scrutiny from the market may impact its stock performance.


Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: August 6, 2026
Last Updated: September 24, 2026

Core portfolio

Awesome Portfolio™

14.8% a year since 2017, against 9.7% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+14.8%

Awesome Portfolio™

+9.7%

S&P/TSX

+5.0 pp better a year

Total return

+254%

Awesome Portfolio™

+134%

S&P/TSX

+119 pp better than the TSX

2017-07-31 to 2026-09-29, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-29
-11.7%42.5%96.7%150.9%205.1%259.3%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement